This study innovates by systematically integrating the molecular mechanisms of iron death and its application in cancer therapy. By deeply analyzing the interaction between iron death and the tumor microenvironment, the study provides a new theoretical basis for cancer treatment and directions for developing more effective treatment strategies. In addition, the study points to critical issues and barriers that need to be addressed in future research, providing valuable insights into the use of iron death in clinical translation.
Recent Advances:
These findings are expected to drive further advances in cancer treatment, bringing patients more treatment options and hope. Through this paper, we see the great potential of iron death in cancer treatment and look forward to more research results being translated into clinical applications in the future to contribute to the fight against cancer.
Critical Issues:
In today’s society, cancer is still one of the major diseases threatening human health. Despite advances in existing treatments, cancer recurrence and drug resistance remain a severe problem. These problems increase the difficulty of treatment and bring a substantial physical and mental burden to patients. Therefore, finding new treatment strategies to overcome these challenges has become significant.
Future Directions:
The study delved into the molecular basis of iron death in tumor biology. It proposed a conceptual framework to account for the interaction of iron death with the tumor immune microenvironment, guide treatment selection, predict efficacy, explore combination therapies, and identify new therapeutic targets to overcome cancer resistance to standard treatments, peeving a path for future research and clinical translation of ferroptosis as a potential strategy in cancer therapy. Antioxid. Redox Signal. 41, 616–636.
Get full access to this article
View all access options for this article.
References
1.
AbdalkaderM, LampinenR, KanninenKM, et al.Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci, 2018; 12:466.
2.
AlanoCC, GarnierP, YingW, et al.NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J Neurosci, 2010; 30(8):2967–2978.
3.
AndrabiSA, DawsonTM, DawsonVL. Mitochondrial and nuclear cross talk in cell death: Parthanatos. Ann N Y Acad Sci, 2008; 1147:233–241.
BadgleyMA, KremerDM, MaurerHC, et al.Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science, 2020; 368(6486):85–89.
6.
BaiL, YanF, DengR, et al.Thioredoxin-1 Rescues MPP(+)/MPTP-Induced Ferroptosis by Increasing Glutathione Peroxidase 4. Mol Neurobiol, 2021; 58(7):3187–3197.
7.
BaoZ, HuaL, YeY, et al.MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma. Neuro Oncol, 2021; 23(12):2014–2027.
8.
BerettaGL, ZaffaroniN. Necroptosis and Prostate Cancer: Molecular mechanisms and therapeutic potential. Cells, 2022; 11(7).
9.
BersukerK, HendricksJM, LiZ, et al.The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 2019; 575(7784):688–692.
10.
BestSA, DE SouzaDP, KersbergenA, et al.Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment. Cell Metab, 2018; 27(4):935–943.e4.
11.
BruedigamC, PorterAH, SongA, et al.Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nat Cancer, 2024; 5(1):47–65.
12.
CaiH, RenY, ChenS, et al.Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors. Front Oncol, 2023; 13:1119369.
13.
CamaschellaC, NaiA, SilvestriL. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica, 2020; 105(2):260–272.
14.
CaoJY, DixonSJ. Mechanisms of ferroptosis. Cell Mol Life Sci, 2016; 73(11–12):2195–2209.
15.
CapellettiMM, ManceauH, PuyH, et al.Ferroptosis in liver diseases: An overview. Int J Mol Sci, 2020; 21(14).
16.
CarauxA, LuQ, FernandezN, et al.Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat Immunol, 2006; 7(7):747–754.
17.
ChenD, FanZ, RauhM, et al.ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene, 2017; 36(40):5593–5608.
18.
ChengY, WangX, HuangS, et al.A CRISPR-Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells. Mol Ther Nucleic Acids, 2023; 34:102063.
19.
ChenZ, JiangJ, FuN, et al.Targeting ferroptosis for blood cell-related diseases. J Drug Target, 2022; 30(3):244–258.
20.
ChenX, LiJ, KangR, et al.Ferroptosis: Machinery and regulation. Autophagy, 2021b;17(9):2054–2081.
21.
ChenX, KangR, KroemerG, et al.Broadening horizons: The role of ferroptosis in cancer. Nat Rev Clin Oncol, 2021a;18(5):280–296.
22.
ChenC, LiuJ, LinX, et al.Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: Insights into apoptosis, autophagy, ferroptosis, and pyroptosis. Cell Death Discov, 2024; 10(1):189.
23.
ChenZ, WangW, Abdul RazakSR, et al.Ferroptosis as a potential target for cancer therapy. Cell Death Dis, 2023; 14(7):460.
24.
ChenX, YuC, KangR, et al.Iron Metabolism in Ferroptosis. Front Cell Dev Biol, 2020; 8:590226.
25.
ChuJ, LiJ, SunL, et al.The role of cellular defense systems of Ferroptosis in Parkinson’s Disease and Alzheimer’s Disease. Int J Mol Sci, 2023; 24.
26.
ConcheC, FinkelmeierF, PešićM, et al.Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut, 2023; 72(9):1774–1782.
27.
ConsoliV, FallicaAN, SorrentiV, et al.Novel Insights on Ferroptosis modulation as potential strategy for cancer treatment: When nature kills. Antioxid Redox Signal, 2024; 40(1–3):40–85.
28.
DaiE, HanL, LiuJ, et al.Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy, 2020a;16(11):2069–2083.
29.
DaiE, HanL, LiuJ, et al.Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway. Nat Commun, 2020b;11(1):6339.
30.
DavidS, JhelumP, RyanF, et al.Dysregulation of Iron homeostasis in the central nervous system and the role of Ferroptosis in Neurodegenerative Disorders. Antioxid Redox Signal, 2022; 37(1–3):150–170.
31.
DE BaatA, MeierDT, FontanaA, et al.Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine production. PLoS One, 2023; 18(10):e0291950.
32.
DE RuysscherD, NiedermannG, BurnetNG, et al.Radiotherapy toxicity. Nat Rev Dis Primers, 2019; 5(1):13.
33.
DengX, WuY, HuZ, et al.The mechanism of ferroptosis in early brain injury after subarachnoid hemorrhage. Front Immunol, 2023; 14:1191826.
34.
DengJ, ZhouM, LiaoT, et al.Targeting cancer cell ferroptosis to reverse immune checkpoint inhibitor therapy resistance. Front Cell Dev Biol, 2022; 10:818453.
35.
DingY, ChenX, LiuC, et al.Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. J Hematol Oncol, 2021; 14(1):19.
36.
DixonSJ, LembergKM, LamprechtMR, et al.Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 2012; 149(5):1060–1072.
37.
DixonSJ, OlzmannJA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol, 2024; 25(6):424–442.
38.
DixonSJ, StockwellBR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol, 2014; 10(1):9–17.
39.
DodsonM, Castro-PortuguezR, ZhangDD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol, 2019; 23:101107.
40.
DollS, FreitasFP, ShahR, et al.FSP1 is a glutathione-independent ferroptosis suppressor. Nature, 2019; 575(7784):693–698.
41.
DrakesmithH, NemethE, GanzT. Ironing out Ferroportin. Cell Metab, 2015; 22(5):777–787.
42.
DuJ, WanZ, WangC, et al.Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy. Theranostics, 2021; 11(17):8185–8196.
43.
DuanQ, ZhangH, ZhengJ, et al.Turning Cold into Hot: Firing up the Tumor Microenvironment. Trends Cancer, 2020; 6(7):605–618.
44.
EbrahimiN, AdelianS, ShakerianS, et al.Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy. Cytokine Growth Factor Rev, 2022; 64:33–45.
45.
EndaleHT, TesfayeW, MengstieTA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol, 2023; 11:1226044.
46.
FaneM, WeeraratnaAT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer, 2020; 20(2):89–106.
47.
FedotchevaT, ShimanovskyN, FedotchevaN. Specific features of mitochondrial dysfunction under conditions of ferroptosis induced by t-butylhydroperoxide and iron: Protective role of the inhibitors of lipid peroxidation and mitochondrial permeability transition pore opening. Membranes (Basel), 2023; 13(4).
48.
Friedmann AngeliJP, KryskoDV, ConradM. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer, 2019; 19(7):405–414.
49.
GalluzziL, VitaleI, AaronsonSA, et al.Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ, 2018; 25(3):486–541.
50.
GalyB, ConradM, MuckenthalerM. Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol, 2024; 25(2):133–155.
51.
GanzT. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 2003; 102(3):783–788.
52.
GaoM, FanK, ChenY, et al.Understanding the mechanistic regulation of ferroptosis in cancer: The gene matters. J Genet Genomics, 2022a;49(10):913–926.
53.
GaoX, HuW, QianD, et al.The mechanisms of ferroptosis under hypoxia. Cell Mol Neurobiol, 2023; 43(7):3329–3341.
54.
GaoW, WangX, ZhouY, et al.Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther, 2022b;7(1):196.
55.
GongD, ChenM, WangY, et al.Role of ferroptosis on tumor progression and immunotherapy. Cell Death Discov, 2022; 8(1):427.
56.
GuZ, LiuT, LiuC, et al.Ferroptosis-strengthened metabolic and inflammatory regulation of tumor-associated macrophages provokes potent tumoricidal activities. Nano Lett, 2021; 21(15):6471–6479.
57.
GuoCM, LiuSQ, SunMZ. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review. Neoplasma, 2020; 67(2):215–228.
58.
GuoL, ZhangQ, LiuY. The role of microRNAs in ferroptosis. Front Mol Biosci, 2022; 9:1003045.
59.
HassanniaB, VandenabeeleP, Vanden BergheT. Targeting Ferroptosis to iron out cancer. Cancer Cell, 2019; 35(6):830–849.
60.
HeJ, WangX, ChenK, et al.The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment. Biochem Pharmacol, 2022; 205:115241.
61.
HenningY, BlindUS, LarafaS, et al.Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction. Cell Death Dis, 2022; 13(7):662.
62.
HoyAJ, NagarajanSR, ButlerLM. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer, 2021; 21(12):753–766.
63.
HuangW, AabedN, ShahYM. Reactive oxygen species and ferroptosis at the nexus of inflammation and colon cancer. Antioxid Redox Signal, 2023a;39(7–9):551–568.
64.
HuangW, ChenK, LuY, et al.ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia, 2021; 23(12):1227–1239.
65.
HuangY, WangS, KeA, et al.Ferroptosis and its interaction with tumor immune microenvironment in liver cancer. Biochim Biophys Acta Rev Cancer, 2023b;1878(1):188848.
66.
HuangZ, XiaH, CuiY, et al.Ferroptosis: From basic research to clinical therapeutics in hepatocellular carcinoma. J Clin Transl Hepatol, 2023c;11(1):207–218.
67.
HuangC, ZhanL. Network pharmacology identifies therapeutic targets and the mechanisms of glutathione action in ferroptosis occurring in oral cancer. Front Pharmacol, 2022; 13:851540.
68.
ItoK, EguchiY, ImagawaY, et al.MPP+ induces necrostatin-1- and ferrostatin-1-sensitive necrotic death of neuronal SH-SY5Y cells. Cell Death Discov, 2017; 3:17013.
69.
JiQ, FuS, ZuoH, et al.ACSL4 is essential for radiation-induced intestinal injury by initiating ferroptosis. Cell Death Discov, 2022; 8(1):332.
70.
JiangX, DengW, TaoS, et al.A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma. Cell Discov, 2023; 9(1):7.
71.
JiangZ, LimSO, YanM, et al.TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Invest, 2021b;131(8).
72.
JiangX, StockwellBR, ConradM. Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol, 2021a;22(4):266–282.
73.
JinX, TangJ, QiuX, et al.Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell Death Discov, 2024; 10(1):45.
74.
JyotsanaN, TaKT, DelgiornoKE. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer. Front Oncol, 2022; 12:858462.
75.
KeK, LiL, LuC, et al.The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer. Front Oncol, 2022; 12:916082.
76.
KimR, HashimotoA, MarkosyanN, et al.Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature, 2022; 612(7939):338–346.
77.
KimS, KangSW, JooJ, et al.Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis, 2021; 12(2):160.
78.
KirtoniaA, SethiG, GargM. The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci, 2020; 77(22):4459–4483.
79.
KoppulaP, LeiG, ZhangY, et al.A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun, 2022; 13(1):2206.
80.
KoppulaP, ZhuangL, GanB. Cystine transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell, 2021; 12(8):599–620.
81.
KrugerS, IlmerM, KoboldS, et al.Advances in cancer immunotherapy 2019—latest trends. J Exp Clin Cancer Res, 2019; 38(1):268.
82.
LaiW, YuL, DengY. PPARγ alleviates preeclampsia development by regulating lipid metabolism and ferroptosis. Commun Biol, 2024; 7(1):429.
83.
LeeJY, KimWK, BaeKH, et al.Lipid Metabolism and Ferroptosis. Biology (Basel), 2021; 10(3).
84.
LeeJ, RohJL. Epithelial-mesenchymal plasticity: Implications for ferroptosis vulnerability and cancer therapy. Crit Rev Oncol Hematol, 2023a;185:103964.
85.
LeeJ, RohJL. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience. Cancer Lett, 2023b;559:216119.
86.
LeiG, MaoC, YanY, et al.Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell, 2021a;12(11):836–857.
87.
LeiG, ZhangY, HongT, et al.Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity. Oncogene, 2021b;40(20):3533–3547.
88.
LeiG, ZhangY, KoppulaP, et al.The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res, 2020; 30(2):146–162.
89.
LeiG, ZhuangL, GanB. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell, 2024; 42(4):513–534.
90.
LiJ, CaoF, YinHL, et al.Ferroptosis: Past, present and future. Cell Death Dis, 2020; 11(2):88.
91.
LiJ, LiuJ, ZhouZ, et al.Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med, 2023a;15(720):eadg3049.
92.
LinD, HuB, ZhuS, et al.Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma. Front Oncol, 2023a;13:1131473.
93.
LinZ, LiuJ, LongF, et al.The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat Commun, 2022; 13(1):7965.
94.
LinL, ZhangMX, ZhangL, et al.Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis. Front Cell Dev Biol, 2021; 9:809955.
95.
LinZ, ZouS, WenK. The crosstalk of CD8+ T cells and ferroptosis in cancer. Front Immunol, 2023b;14:1255443.
96.
LiQ, PengF, YanX, et al.Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro. J Ethnopharmacol, 2023b;303:116029.
97.
LiuX, CaoZ, WangW, et al.Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma. ACS Nano, 2023b;17(17):16432–16447.
98.
LiuY, ChenQ, ZhuY, et al.Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis. Cell Death Discov, 2021c;7(1):210.
99.
LiuM, FanY, LiD, et al.Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol, 2021a;15(8):2084–2105.
100.
LiuMY, LiHM, WangXY, et al.TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway. Free Radic Biol Med, 2022a;182:219–231.
101.
LiuY, LuS, WuLL, et al.The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis, 2023c;14(8):519.
102.
LiuY, TanS, WuY, et al.The Emerging Role of Ferroptosis in Sepsis. DNA Cell Biol, 2022c;41(4):368–380.
103.
LiuY, WangY, LinZ, et al.SLC25A22 as a Key Mitochondrial Transporter Against Ferroptosis by Producing Glutathione and Monounsaturated Fatty Acids. Antioxid Redox Signal, 2023d;39(1–3):166–185.
104.
LiuL, YeY, LinR, et al.Ferroptosis: A promising candidate for exosome-mediated regulation in different diseases. Cell Commun Signal, 2024; 22(1):6.
105.
LiuS, ZhangHL, LiJ, et al.Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis. Redox Biol, 2023a;62:102677.
106.
LiuX, ZhangY, WuX, et al.Targeting Ferroptosis pathway to combat therapy resistance and metastasis of cancer. Front Pharmacol, 2022b;13:909821.
107.
LiuMR, ZhuWT, PeiDS. System Xc(-):A key regulatory target of ferroptosis in cancer. Invest New Drugs, 2021b;39(4):1123–1131.
108.
LiD, WangT, LaiJ, et al.Silencing TRPM2 enhanced erastin- and RSL3-induced ferroptosis in gastric cancer cells through destabilizing HIF-1α and Nrf2 proteins. Cytotechnology, 2022; 74(5):559–577.
109.
LiY, YangW, ZhengY, et al.Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. J Exp Clin Cancer Res, 2023d;42(1):6.
110.
LiT, ZhaoL, LiY, et al.PPM1K mediates metabolic disorder of branched-chain amino acid and regulates cerebral ischemia-reperfusion injury by activating ferroptosis in neurons. Cell Death Dis, 2023c;14(9):634.
111.
LleonartME, AbadE, GraiferD, et al.Reactive Oxygen Species-Mediated Autophagy Defines the Fate of Cancer Stem Cells. Antioxid Redox Signal, 2018; 28(11):1066–1079.
112.
LogieE, VAN PuyveldeB, CuypersB, et al.Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence. Int J Mol Sci, 2021; 22(22).
113.
LuL, ChenB, XuY, et al.Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer. Front Pharmacol, 2022; 13:902302.
114.
LuoJ, SongG, ChenN, et al.Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation. Cell Death Discov, 2023a;9(1):311.
115.
LuoM, YanJ, HuX, et al.Targeting lipid metabolism for ferroptotic cancer therapy. Apoptosis, 2023b;28(1–2):81–107.
116.
MaT, DuJ, ZhangY, et al.GPX4-independent ferroptosis-a new strategy in disease’s therapy. Cell Death Discov, 2022; 8(1):434.
117.
MaLL, LiangL, ZhouD, et al.Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4. Neoplasma, 2021; 68(1):165–173.
118.
MaoC, GanB. Navigating ferroptosis via an NADPH sensor. Nat Cell Biol, 2022; 24(8):1186–1187.
119.
MaoC, WangM, ZhuangL, et al.Metabolic cell death in cancer: Ferroptosis, cuproptosis, disulfidptosis, and beyond. Protein Cell, 2024
120.
MatsushitaM, FreigangS, SchneiderC, et al.T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med, 2015; 212(4):555–568.
121.
MiaoY, ChenY, XueF, et al.Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression. EBioMedicine, 2022; 76:103847.
122.
MishimaE, ItoJ, WuZ, et al.A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature, 2022; 608(7924):778–783.
123.
MorganPK, PernesG, HuynhK, et al.A lipid atlas of human and mouse immune cells provides insights into ferroptosis susceptibility. Nat Cell Biol, 2024; 26(4):645–659.
MotookaY, ToyokuniS. Ferroptosis As ultimate target of cancer therapy. Antioxid Redox Signal, 2023; 39(1–3):206–223.
126.
NakamuraT, HippC, Santos Dias MourãoA, et al.Phase separation of FSP1 promotes ferroptosis. Nature, 2023; 619(7969):371–377.
127.
NishizawaH, MatsumotoM, ChenG, et al.Lipid peroxidation and the subsequent cell death transmitting from ferroptotic cells to neighboring cells. Cell Death Dis, 2021; 12(4):332.
128.
OhM, JangSY, LeeJY, et al.The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. Nat Commun, 2023; 14(1):5728.
129.
ParkM, ParkS, ChoiY, et al.The mechanism underlying correlation of particulate matter-induced ferroptosis with inflammasome activation and iron accumulation in macrophages. Cell Death Discov, 2024; 10(1):144.
QiuY, YuT, WangW, et al.Curcumin-induced melanoma cell death is associated with mitochondrial permeability transition pore (mPTP) opening. Biochem Biophys Res Commun, 2014; 448(1):15–21.
132.
RamirezCFA, TarantoD, Ando-KuriM, et al.Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma. Nat Commun, 2024; 15(1):2581.
133.
RayatpourA, FooladF, HeibatollahiM, et al.Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve. Sci Rep, 2022; 12(1):19630.
134.
RochetteL, DogonG, RigalE, et al.Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci, 2022; 24(1).
135.
RodriguezR, SchreiberSL, ConradM. Persister cancer cells: Iron addiction and vulnerability to ferroptosis. Mol Cell, 2022; 82(4):728–740.
136.
RosatoRR, Dávila-GonzálezD, ChoiDS, et al.Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models. Breast Cancer Res, 2018; 20(1):108.
137.
RosellR, JainA, Codony-ServatJ, et al.Biological insights in non-small cell lung cancer. Cancer Biol Med, 2023; 20(7):500–518.
138.
ShanG, ZhangH, BiG, et al.Multi-Omics Analysis of Cancer Cell Lines with High/Low Ferroptosis Scores and Development of a Ferroptosis-Related Model for Multiple Cancer Types. Front Cell Dev Biol, 2021; 9:794475.
139.
SheikhA, KesharwaniP, AlmalkiWH, et al.Understanding the Novel Approach of Nanoferroptosis for cancer therapy. Nanomicro Lett, 2024; 16(1):188.
140.
ShenY, LiX, DongD, et al.Transferrin receptor 1 in cancer: A new sight for cancer therapy. Am J Cancer Res, 2018a;8:916–931.
141.
ShenY, LiD, LiangQ, et al.Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma. Front Immunol, 2022; 13:1029092.
142.
ShenZ, LiuT, LiY, et al.Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors. ACS Nano, 2018b;12(11):11355–11365.
143.
ShinD, KimEH, LeeJ, et al.Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med, 2018; 129:454–462.
144.
ShinD, LeeJ, RohJL. Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine. Cancer Lett, 2024; 585:216645.
145.
StockwellBR, Friedmann AngeliJP, BayirH, et al.Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. Cell, 2017; 171(2):273–285.
146.
StockwellBR, JiangX, GuW. Emerging mechanisms and disease relevance of Ferroptosis. Trends Cell Biol, 2020; 30(6):478–490.
147.
StrippoliR, Niayesh-MehrR, AdelipourM, et al.Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression. Cancers (Basel), 2024; 16(4).
148.
TanL, ShenX, HeZ, et al.The role of photodynamic therapy in triggering cell death and facilitating antitumor immunology. Front Oncol, 2022; 12:863107.
149.
TangR, WuZ, RongZ, et al.Ferroptosis-related lncRNA pairs to predict the clinical outcome and molecular characteristics of pancreatic ductal adenocarcinoma. Brief Bioinform, 2022b;23(1).
150.
TangB, YanR, ZhuJ, et al.Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types. Int J Biol Sci, 2022a;18(1):180–198.
151.
TangB, ZhuJ, FanLI J, et al.The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal, 2020; 18(1):174.
152.
TianHY, HuangBY, NieHF, et al.The Interplay between Mitochondrial Dysfunction and Ferroptosis during Ischemia-Associated Central Nervous System Diseases. Brain Sci, 2023; 13(10).
153.
TianM, MaoL, ZhangL. Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries. Front Cell Neurosci, 2022; 16:1013450.
154.
TomaszG, EwaW, JolantaM. Biomarkers of iron metabolism in chronic kidney disease. Int Urol Nephrol, 2021; 53(5):935–944.
155.
UrsiniF, MaiorinoM. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med, 2020; 152:175–185.
156.
ValashediMR, Najafi-GhalehlouN, NikooA, et al.Cashing in on ferroptosis against tumor cells: Usher in the next chapter. Life Sci, 2021; 285:119958.
157.
Vanden BergheT, LinkermannA, Jouan-LanhouetS, et al.Regulated necrosis: The expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol, 2014; 15(2):135–147.
158.
VinodSK, HauE. Radiotherapy treatment for lung cancer: Current status and future directions. Respirology, 2020; 25 Suppl 2:61–71.
159.
WangH, ChengY, MaoC, et al.Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther, 2021; 29(7):2185–2208.
160.
WangL, MaQ, YaoR, et al.Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer. Int Immunopharmacol, 2020; 79:106088.
161.
WangJ, WangZ, WangLI L, et al.Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy. Acta Biomater, 2024; 181:362–374.
162.
WohlhieterCA, RichardsAL, UddinF, et al.Concurrent Mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer. Cell Rep, 2020; 33(9):108444.
163.
XiaX, FanX, ZhaoM, et al.The relationship between Ferroptosis and Tumors: A novel landscape for therapeutic approach. Curr Gene Ther, 2019; 19(2):117–124.
164.
XiaoC, FuX, WangY, et al.Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation. PLoS One, 2020; 15(12):e0243812.
165.
XuL, LiuY, ChenX, et al.Ferroptosis in life: To be or not to be. Biomed Pharmacother, 2023; 159:114241.
166.
XuC, SunS, JohnsonT, et al.The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep, 2021a;35(11):109235.
167.
XuH, YeD, RenM, et al.Ferroptosis in the tumor microenvironment: Perspectives for immunotherapy. Trends Mol Med, 2021b;27(9):856–867.
168.
YadavVK, ChoudharyN, GacemA, et al.Deeper insight into ferroptosis: association with Alzheimer’s, Parkinson’s disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis. Redox Rep, 2023; 28(1):2269331.
169.
YangX, DuanS, LiZ, et al.Protocol of CRISPR-Cas9 knockout screens for identifying ferroptosis regulators. STAR Protoc, 2023b;4(4):102762.
170.
YangWS, KimKJ, GaschlerMM, et al.Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A, 2016; 113(34):E4966–75.
171.
YangWS, SriramaratnamR, WelschME, et al.Regulation of ferroptotic cancer cell death by GPX4. Cell, 2014; 156(1–2):317–331.
172.
YangWS, StockwellBR. Ferroptosis: Death by Lipid Peroxidation. Trends Cell Biol, 2016; 26(3):165–176.
173.
YangM, TsuiMG, TsangJKW, et al.Involvement of FSP1-CoQ(10)-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis. Cell Death Dis, 2022; 13(5):468.
174.
YangF, XiaoY, DingJH, et al.Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab, 2023a;35(1):84–100.e8.
175.
YaoY, ChenZ, ZhangH, et al.Author Correction: Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat Immunol, 2021d;22(12):1599.
176.
YaoF, DengY, ZhaoY, et al.A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun, 2021a;12(1):7333.
177.
YaoX, LiW, FangD, et al.Emerging roles of energy metabolism in Ferroptosis Regulation of Tumor Cells. Adv Sci (Weinh), 2021b;8(22):e2100997.
178.
YaoX, XieR, CaoY, et al.Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnology, 2021c;19(1):311.
179.
YaoX, YangB, WangS, et al.A novel multifunctional FePt/BP nanoplatform for synergistic photothermal/photodynamic/chemodynamic cancer therapies and photothermally-enhanced immunotherapy. J Mater Chem B, 2020; 8(35):8010–8021.
180.
YazğanY, NaziroğluM. Ovariectomy-induced mitochondrial oxidative stress, apoptosis, and calcium ion influx through TRPA1, TRPM2, and TRPV1 are prevented by 17β-estradiol, tamoxifen, and raloxifene in the hippocampus and dorsal root ganglion of rats. Mol Neurobiol, 2017; 54(10):7620–7638.
181.
YeF, LiX, LiF, et al.Cyclosporin A protects against Lead neurotoxicity through inhibiting mitochondrial permeability transition pore opening in nerve cells. Neurotoxicology, 2016; 57:203–213.
182.
YinL, LiuP, JinY, et al.Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications. Eur J Med Chem, 2022; 244:114861.
183.
YuanS, WeiC, LiuG, et al.Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. Cell Prolif, 2022; 55(1):e13158.
184.
YuL, HuangK, LiaoY, et al.Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1/PD-L1 cancer immunotherapy. Cell Prolif, 2024:e13644.
185.
YuW, LiuW, XieD, et al.High Level of Uric Acid Promotes Atherosclerosis by Targeting NRF2-Mediated Autophagy Dysfunction and Ferroptosis. Oxid Med Cell Longev, 2022; 2022:9304383.
186.
YunT, LiuZ, WangJ, et al.Microenvironment immune response induced by tumor ferroptosis-the application of nanomedicine. Front Oncol, 2022; 12:1019654.
187.
YuY, XieY, CaoL, et al.The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol, 2015; 2(4):e1054549.
188.
YuY, YanY, NiuF, et al.Ferroptosis: A cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov, 2021; 7(1):193.
189.
ZhangH, DengT, LiuR, et al.CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer, 2020; 19(1):43.
190.
ZhangS, GouS, ZhangQ, et al.FSP1 oxidizes NADPH to suppress ferroptosis. Cell Res, 2023; 33(12):967–970.
191.
ZhangC, LiuN. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer. Front Immunol, 2022; 13:920059.
192.
ZhangM, LiuJ, YuY, et al.Recent Advances in the Inhibition of Membrane Lipid Peroxidation by Food-Borne Plant Polyphenols via the Nrf2/GPx4 Pathway. J Agric Food Chem, 2024; 72(22):12340–12355.
193.
ZhangN, YuX, SongL, et al.Ferritin confers protection against iron-mediated neurotoxicity and ferroptosis through iron chelating mechanisms in MPP(+)-induced MES23.5 dopaminergic cells. Free Radic Biol Med, 2022; 193(Pt 2):751–763.
194.
ZhaoJ, JiaY, MahmutD, et al.Human hematopoietic stem cell vulnerability to ferroptosis. Cell, 2023; 186(4):732–747.e16.
195.
ZhaoS, LiP, WuW, et al.Roles of ferroptosis in urologic malignancies. Cancer Cell Int, 2021b;21(1):676.
196.
ZhaoL, PengY, HeS, et al.Apatinib induced ferroptosis by lipid peroxidation in gastric cancer. Gastric Cancer, 2021a;24(3):642–654.
197.
ZhengX, JinX, YeF, et al.Ferroptosis: A novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Exp Hematol Oncol, 2023; 12(1):65.
198.
ZhongY, TianF, MaH, et al.FTY720 induces ferroptosis and autophagy via PP2A/AMPK pathway in multiple myeloma cells. Life Sci, 2020; 260:118077.
199.
ZhouZ, LuJ, MaJ, et al.Identification of Potential Ferroptosis Key Genes in the Pathogenesis of Lumbosacral Spinal Root Avulsion by RNA Sequencing and Bioinformatics Analysis. Front Mol Biosci, 2022; 9:902607.
200.
ZhouQ, MengY, LiD, et al.Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther, 2024; 9(1):55.
201.
ZhuangF, ShiX, QiaoS, et al.Allicin promotes functional recovery in ischemic stroke via glutathione peroxidase-1 activation of Src-Akt-Erk. Cell Death Discov, 2023; 9(1):335.
202.
ZhuH, KlementJD, LuC, et al.Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. J Immunol, 2021; 206(6):1395–1404.
203.
ZhuD, WuS, LiY, et al.Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma. Cancer Cell Int, 2022; 22(1):124.
204.
ZouJ, WangL, TangH, et al.Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It. Int J Mol Sci, 2021; 22(24).
